CRISPR Therapeutics AG (CRSP)
57.23
+5.02
(+9.62%)
USD |
NASDAQ |
Sep 17, 14:53
CRISPR Therapeutics Market Cap : 5.532B for Sept. 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 5.047B |
| September 15, 2026 | 5.010B |
| September 14, 2026 | 5.119B |
| September 11, 2026 | 4.999B |
| September 10, 2026 | 5.052B |
| September 09, 2026 | 5.167B |
| September 08, 2026 | 5.295B |
| September 04, 2026 | 5.393B |
| September 03, 2026 | 5.460B |
| September 02, 2026 | 5.502B |
| September 01, 2026 | 5.492B |
| August 31, 2026 | 5.508B |
| August 28, 2026 | 5.579B |
| August 27, 2026 | 5.739B |
| August 26, 2026 | 5.725B |
| August 25, 2026 | 5.887B |
| August 24, 2026 | 5.517B |
| August 21, 2026 | 5.751B |
| August 20, 2026 | 5.618B |
| August 19, 2026 | 5.781B |
| August 18, 2026 | 5.120B |
| August 17, 2026 | 5.247B |
| August 14, 2026 | 5.176B |
| August 13, 2026 | 5.219B |
| August 12, 2026 | 5.219B |
| Date | Value |
|---|---|
| August 11, 2026 | 5.226B |
| August 10, 2026 | 5.172B |
| August 07, 2026 | 5.173B |
| August 06, 2026 | 4.992B |
| August 05, 2026 | 5.070B |
| August 04, 2026 | 5.130B |
| August 03, 2026 | 4.791B |
| July 31, 2026 | 4.639B |
| July 30, 2026 | 4.682B |
| July 29, 2026 | 4.592B |
| July 28, 2026 | 4.583B |
| July 27, 2026 | 4.504B |
| July 24, 2026 | 4.486B |
| July 23, 2026 | 4.581B |
| July 22, 2026 | 4.553B |
| July 21, 2026 | 4.641B |
| July 20, 2026 | 4.529B |
| July 17, 2026 | 4.605B |
| July 16, 2026 | 4.681B |
| July 15, 2026 | 4.951B |
| July 14, 2026 | 4.864B |
| July 13, 2026 | 4.880B |
| July 10, 2026 | 5.142B |
| July 09, 2026 | 5.430B |
| July 08, 2026 | 5.706B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 130.05B |
| Basilea Pharmaceutica AG | 959.99M |
| Santhera Pharmaceuticals Holding AG | 265.06M |
| BeOne Medicines Ltd. | 36.81B |
| AC Immune SA | 244.15M |
Market Cap Related Metrics
| PS Ratio | 405.06 |
| Price to Book Value | 3.167 |
| Price | 57.23 |
| Earnings Yield | -8.32% |